1 September 2014

Saving lives, averting costs

An analysis of the financial implications of achieving earlier diagnosis of colorectal, lung and ovarian cancer

Evoke Incisive Health was commissioned by Cancer Research UK to analyse the financial consequences of earlier diagnosis in planning cancer services. Our findings show that there is a clear financial dividend from earlier diagnosis, as well as a compelling case for improving cancer survival.

We think you may also like...

New report delivers ways to increase cancer service capacity

By Evoke Incisive Health

26 March 2023

Bridging Europe's gender health gap

By Evoke Incisive Health

13 March 2023

Delivering for people living with rare diseases

By Evoke Incisive Health

28 February 2023

Join us in making health more human™

If you like how we think, what we offer, and our mission to make health more human™, check out our open roles.

Inizio logo

We are proudly part of Inizio

Inizio is a strategic partner for companies in health and life sciences that connects a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services across the lifecycle of a drug.

Learn more